Integral Health Asset Management, LLC
CIK 1773206 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $2.5B
- Posisi
- 92
- Per tanggal
- 30 Juni 2026
#1.311 dari 9.443 berdasarkan nilai 13F · top 13.9%
Nilai portofolio QoQ: +21.1% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 44,81%
- Bobot 25 kepemilikan teratas
- 68,68%
- Posisi di atas 1%
- 29
- Jumlah posisi efektif
- 30,6
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 25,34% Perkiraan pembelian $767.853.150 · penjualan $585.729.150
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 45,5% masih dipegang
- Posisi baru
- 31
- Meningkat
- 23
- Menurun
- 21
- Tertutup
- 25
Eksposur put-notional: 2,2% put 13F melaporkan posisi opsi pada nilai notional yang mendasarinya — dapat mencakup lindung nilai, tidak selalu taruhan bearish
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +41.2% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 99,1% · Opsi dikecualikan: 5,1%
Rincian sektor
Healthcare
98,2%
Lainnya/Tidak terpetakan
1,8%
Portofolio lengkap 92 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. - Common Stock | $280.920.000 | 11,10% | 1.500.000 | $135.045.000 | |||
| INSM Insmed Incorporated - Common Stock | $170.592.000 | 6,74% | 1.600.000 | $-74.688.000 | Naik ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $136.304.000 | 5,38% | 1.600.000 | $30.848.000 | |||
| CVS CVS Health Corporation Common Stock | $113.795.000 | 4,49% | 1.100.000 | $103.022.000 | Naik ×1 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $81.260.000 | 3,21% | 2.000.000 | $30.860.000 | Naik ×2 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $75.092.500 | 2,97% | 1.750.000 | $10.724.500 | Naik ×1 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $73.431.000 | 2,90% | 300.000 | $67.515.300 | Naik ×1 | ||
| CAH Cardinal Health, Inc. Common Stock | $71.268.000 | 2,81% | 300.000 | $14.214.300 | Naik ×3 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $70.780.000 | 2,80% | 2.000.000 | $15.380.000 | |||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $61.066.500 | 2,41% | 550.000 | $8.884.500 | Turun ×1 | ||
| EW Edwards Lifesciences Corporation Common Stock | $56.537.500 | 2,23% | 625.000 | $42.923.900 | Naik ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $56.184.000 | 2,22% | 300.000 | Opsi jual | $-16.753.500 | Turun ×1 | |
| ALHC Alignment Healthcare, Inc. - Common Stock | $47.620.000 | 1,88% | 2.000.000 | $2.248.500 | Turun ×1 | ||
| MRK Merck & Company, Inc. Common Stock (new) | $44.975.000 | 1,78% | 350.000 | $-6.148.250 | Turun ×1 | ||
| DGX Quest Diagnostics Incorporated Common Stock | $42.390.000 | 1,67% | 200.000 | $30.631.200 | Naik ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $41.454.000 | 1,64% | 900.000 | $26.739.000 | |||
| SRRK Scholar Rock Holding Corporation - Common Stock | $41.250.000 | 1,63% | 750.000 | $16.670.000 | Naik ×3 | ||
| BSX Boston Scientific Corporation Common Stock | $38.412.000 | 1,52% | 900.000 | $3.899.500 | Naik ×2 | ||
| BTSG BrightSpring Health Services, Inc. - Common Stock | $38.357.000 | 1,52% | 550.000 | $-14.905.500 | Turun ×1 | ||
| ABT Abbott Laboratories Common Stock | $36.296.000 | 1,43% | 400.000 | Naik ×1 | |||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $35.328.550 | 1,40% | 85.000 | ||||
| LFST LifeStance Health Group, Inc. - Common Stock | $32.130.000 | 1,27% | 3.000.000 | $4.739.000 | Turun ×1 | ||
| NVS Novartis AG Common Stock | $31.344.000 | 1,24% | 200.000 | $-6.843.500 | Turun ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $31.260.000 | 1,23% | 1.000.000 | $21.846.000 | Naik ×2 | ||
| THC Tenet Healthcare Corporation Common Stock | $30.868.200 | 1,22% | 165.000 | ||||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $28.853.500 | 1,14% | 325.000 | Naik ×1 | |||
| NVO Novo Nordisk A/S Common Stock | $28.764.000 | 1,14% | 600.000 | Naik ×1 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $25.872.000 | 1,02% | 550.000 | $18.312.000 | Naik ×1 | ||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $25.281.000 | 1,00% | 150.000 | $5.520.000 | |||
| REGN Regeneron Pharmaceuticals, Inc. - Common Stock | $24.941.600 | 0,99% | 40.000 | $-40.732.800 | Turun ×2 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $23.787.000 | 0,94% | 300.000 | Opsi beli | Naik ×1 | ||
| BIIB Biogen Inc. - Common Stock | $21.606.000 | 0,85% | 100.000 | $10.606.200 | Naik ×1 | ||
| TVTX Travere Therapeutics, Inc. - Common Stock | $21.303.750 | 0,84% | 375.000 | ||||
| LNTH Lantheus Holdings, Inc. - Common Stock | $21.078.600 | 0,83% | 190.000 | $11.597.350 | Naik ×2 | ||
| GKOS Glaukos Corporation Common Stock | $20.964.000 | 0,83% | 150.000 | $2.123.500 | Turun ×2 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $20.577.000 | 0,81% | 1.900.000 | $2.839.000 | Naik ×3 | ||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $20.482.000 | 0,81% | 275.000 | $60.500 | |||
| VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $19.869.200 | 0,78% | 40.000 | $2.007.600 | |||
| ALMS Alumis Inc. - Common Stock | $19.698.000 | 0,78% | 700.000 | $2.074.000 | Turun ×1 | ||
| ELV Elevance Health, Inc. Common Stock | $19.336.500 | 0,76% | 50.000 | $-2.619.750 | Turun ×1 | ||
| CNC Centene Corporation Common Stock | $19.257.000 | 0,76% | 300.000 | $-2.024.000 | Turun ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $18.320.000 | 0,72% | 1.000.000 | $6.994.000 | Naik ×1 | ||
| LLY Eli Lilly and Company Common Stock | $17.991.450 | 0,71% | 15.000 | $4.194.900 | |||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $16.302.000 | 0,64% | 200.000 | $-2.508.000 | Turun ×1 | ||
| NVST Envista Holdings Corporation Common Stock | $15.810.000 | 0,62% | 600.000 | $6.930.500 | Naik ×1 | ||
| MDT Medtronic plc. Ordinary Shares | $15.646.000 | 0,62% | 200.000 | ||||
| WAT Waters Corporation Common Stock | $15.001.600 | 0,59% | 40.000 | ||||
| LIVN LivaNova PLC - Ordinary Shares | $14.801.400 | 0,58% | 180.000 | $5.267.400 | Naik ×1 | ||
| NVO Novo Nordisk A/S Common Stock | $14.382.000 | 0,57% | 300.000 | Opsi beli | Naik ×1 | ||
| FBRX Forte Biosciences, Inc. - Common Stock | $14.343.750 | 0,57% | 675.000 | $10.458.750 | Naik ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $13.423.750 | 0,53% | 25.000 | $337.000 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $13.391.600 | 0,53% | 40.000 | $504.000 | |||
| ANRO Alto Neuroscience, Inc. Common Stock | $13.195.000 | 0,52% | 500.000 | $1.955.000 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $12.141.000 | 0,48% | 450.000 | $-8.176.500 | Turun ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $12.072.000 | 0,48% | 200.000 | $442.000 | |||
| Penerbit tidak dikenal (CUSIP: K08588103) | $12.002.400 | 0,47% | 45.000 | Naik ×1 | |||
| ACHC Acadia Healthcare Company, Inc. - Common Stock | $11.812.000 | 0,47% | 400.000 | $7.134.000 | Naik ×1 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $10.705.500 | 0,42% | 90.000 | ||||
| BHVN Biohaven Ltd. Common Shares | $10.416.000 | 0,41% | 700.000 | $1.956.000 | Turun ×2 | ||
| BEAM Beam Therapeutics Inc. - Common Stock | $10.296.000 | 0,41% | 300.000 | $3.147.000 | |||
| IART Integra LifeSciences Holdings Corporation - Common Stock | $9.878.000 | 0,39% | 550.000 | Naik ×1 | |||
| GEHC GE HealthCare Technologies Inc. - Common Stock | $9.601.500 | 0,38% | 150.000 | ||||
| RGNX REGENXBIO Inc. - Common Stock | $9.584.000 | 0,38% | 800.000 | $-2.986.000 | Turun ×1 | ||
| ABSI Absci Corporation - Common Stock | $9.272.000 | 0,37% | 800.000 | Naik ×1 | |||
| BRKR Bruker Corporation - Common Stock | $9.027.000 | 0,36% | 150.000 | ||||
| COR Cencora, Inc. Common Stock | $8.489.400 | 0,34% | 30.000 | Naik ×1 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $7.740.000 | 0,31% | 200.000 | $-5.731.500 | Turun ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $7.612.500 | 0,30% | 150.000 | Naik ×1 | |||
| BIOA BioAge Labs, Inc. - Common Stock | $7.353.000 | 0,29% | 300.000 | Naik ×1 | |||
| JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | $7.229.100 | 0,29% | 30.000 | Naik ×1 | |||
| SANA Sana Biotechnology, Inc. - Common Stock | $6.980.000 | 0,28% | 2.000.000 | $-2.236.000 | Turun ×1 | ||
| IVA Inventiva S.A. - American Depository Shares | $5.745.600 | 0,23% | 1.520.000 | $3.525.600 | Naik ×1 | ||
| TARA Protara Therapeutics, Inc. - Common Stock | $5.730.000 | 0,23% | 1.500.000 | $-3.387.500 | Turun ×2 | ||
| ALKS Alkermes plc - Ordinary Shares | $5.239.500 | 0,21% | 100.000 | ||||
| LBRX LB Pharmaceuticals Inc - Common Stock | $4.868.250 | 0,19% | 150.000 | $1.169.250 | |||
| Penerbit tidak dikenal (CUSIP: 485925101) | $4.770.000 | 0,19% | 200.000 | Naik ×1 | |||
| BNTX BioNTech SE - American Depositary Shares | $4.652.500 | 0,18% | 50.000 | ||||
| INSP Inspire Medical Systems, Inc. Common Stock | $4.461.000 | 0,18% | 100.000 | ||||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $3.730.000 | 0,15% | 200.000 | Naik ×1 | |||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $3.727.000 | 0,15% | 100.000 | Naik ×1 | |||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $3.721.000 | 0,15% | 100.000 | Naik ×1 | |||
| SVRA Savara, Inc. - Common Stock | $3.696.000 | 0,15% | 600.000 | $420.000 | |||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $3.460.000 | 0,14% | 500.000 | $328.000 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 60705V103) | $3.350.000 | 0,13% | 250.000 | Naik ×1 | |||
| SION Sionna Therapeutics, Inc. - Common Stock | $3.299.250 | 0,13% | 75.000 | $1.294.750 | Naik ×1 | ||
| MANE Veradermics, Incorporated Common Stock | $3.073.500 | 0,12% | 25.000 | Naik ×1 | |||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $2.740.500 | 0,11% | 1.350.000 | $472.500 | |||
| RZLT Rezolute, Inc. - Common Stock (NV) | $2.600.000 | 0,10% | 500.000 | $-3.500.000 | Turun ×1 | ||
| DNLI Denali Therapeutics Inc. - Common Stock | $2.572.000 | 0,10% | 100.000 | Naik ×1 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $2.429.850 | 0,10% | 167.000 | $-240.480 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $1.251.000 | 0,05% | 100.000 | $-985.500 | Turun ×1 | ||
| AURA Aura Biosciences, Inc. - Common Stock | $1.207.000 | 0,05% | 170.000 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ABT | $36.296.000 | 400.000 | 1,43% |
| UNH | $35.328.550 | 85.000 | 1,40% |
| THC | $30.868.200 | 165.000 | 1,22% |
| SYRE | $28.853.500 | 325.000 | 1,14% |
| NVO | $28.764.000 | 600.000 | 1,14% |
| IONS | $23.787.000 | 300.000 | 0,94% |
| TVTX | $21.303.750 | 375.000 | 0,84% |
| MDT | $15.646.000 | 200.000 | 0,62% |
| WAT | $15.001.600 | 40.000 | 0,59% |
| NVO | $14.382.000 | 300.000 | 0,57% |
| Penerbit tidak dikenal (CUSIP: K08588103) | $12.002.400 | 45.000 | 0,47% |
| IRTC | $10.705.500 | 90.000 | 0,42% |
| IART | $9.878.000 | 550.000 | 0,39% |
| GEHC | $9.601.500 | 150.000 | 0,38% |
| ABSI | $9.272.000 | 800.000 | 0,37% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Hanya pergerakan harga | +0 | +$135.0M |
| INSM | Beli lebih banyak | +100K | -$74.7M |
| EW | Beli lebih banyak | +455K | +$42.9M |
| REGN | Dipangkas | -45K | -$40.7M |
| EWTX | Beli lebih banyak | +400K | +$30.9M |
| CYTK | Hanya pergerakan harga | +0 | +$30.8M |
| DGX | Beli lebih banyak | +140K | +$30.6M |
| QURE | Hanya pergerakan harga | +0 | +$26.7M |
| TNGX | Beli lebih banyak | +550K | +$21.8M |
| DFTX | Beli lebih banyak | +150K | +$18.3M |
2 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| MDT | 31 Maret 2026 | 675.000 | $64.840.500 | 6,3% |
| AZN | 30 Juni 2026 | 250.000 | $49.305.000 | -12,7% |
| TEVA | 31 Maret 2026 | 1.000.000 | $31.210.000 | 23,4% |
| PEN | 31 Maret 2026 | 100.000 | $31.091.000 | -1,3% |
| TFX | 31 Maret 2026 | 250.000 | $30.510.000 | 12,8% |
| CNC | 31 Maret 2025 | 500.000 | $30.290.000 | 5,7% |
| CAH | 31 Maret 2025 | 250.000 | $29.567.500 | 67,4% |
| LLY | 31 Maret 2025 | 38.000 | $29.336.000 | 51,3% |
| NAMS | 31 Des. 2025 | 1.000.000 | $28.440.000 | -20,2% |
| ASND | 30 Juni 2026 | 115.000 | $26.303.950 | -3,3% |
| ALNY | 31 Maret 2026 | 60.000 | $23.859.000 | -30,6% |
| IRTC | 31 Maret 2026 | 130.000 | $23.067.200 | 8,6% |
| NVO | 31 Des. 2025 | 400.000 | $22.196.000 | -8,2% |
| ISRG | 31 Maret 2025 | 40.000 | $20.878.400 | -24,6% |
| UPB | 31 Maret 2026 | 750.000 | $20.362.500 | -22,7% |
| MRK | 31 Maret 2025 | 200.000 | $19.896.000 | 69,0% |
| THC | 31 Maret 2026 | 100.000 | $19.872.000 | 45,5% |
| DGX | 31 Maret 2025 | 130.000 | $19.611.800 | 42,2% |
| GILD | 30 Juni 2025 | 175.000 | $19.608.750 | 30,6% |
| NARI | 31 Maret 2025 | 350.000 | $17.867.500 | Tidak lagi dilacak |
| DOCS | 31 Maret 2026 | 400.000 | $17.712.000 | 9,5% |
| FMS | 30 Juni 2026 | 775.000 | $17.484.000 | 3,6% |
| DXCM | 30 Sep. 2025 | 200.000 | $17.458.000 | 32,9% |
| TERN | 31 Maret 2026 | 425.000 | $17.170.000 | Tidak lagi dilacak |
| UNH | 31 Maret 2026 | 50.000 | $16.505.500 | 43,1% |
| ISRG | 30 Juni 2026 | 35.000 | $16.134.650 | -6,1% |
| ASND | 30 Juni 2025 | 100.000 | $15.586.000 | 49,4% |
| GEHC | 30 Sep. 2025 | 200.000 | $14.814.000 | -1,4% |
| AZN | 31 Maret 2025 | 225.000 | $14.742.000 | 125,2% |
| RDNT | 31 Maret 2026 | 200.000 | $14.270.000 | 36,3% |
| TARS | 30 Juni 2026 | 200.000 | $14.030.000 | 14,8% |
| GILD | 30 Juni 2026 | 100.000 | $13.937.000 | 14,6% |
| APLS | 31 Maret 2025 | 420.000 | $13.402.200 | Tidak lagi dilacak |
| ELAN | 30 Juni 2026 | 550.000 | $13.161.500 | -2,3% |
| ACLX | 30 Juni 2025 | 200.000 | $13.120.000 | Tidak lagi dilacak |
| ACLX | 31 Maret 2026 | 200.000 | $13.040.000 | Tidak lagi dilacak |
| BPMC | 30 Juni 2025 | 145.000 | $12.833.950 | Tidak lagi dilacak |
| PFE | 31 Des. 2025 | 500.000 | $12.740.000 | 12,7% |
| DNTH | 30 Juni 2026 | 150.000 | $12.588.000 | 14,7% |
| MCK | 31 Des. 2025 | 15.000 | $11.588.100 | 4,4% |
| A | 31 Des. 2025 | 90.000 | $11.551.500 | 15,0% |
| DXCM | 30 Juni 2026 | 175.000 | $10.990.000 | 32,8% |
| EXAS | 31 Des. 2025 | 200.000 | $10.942.000 | Tidak lagi dilacak |
| SLNO | 30 Juni 2026 | 325.000 | $10.881.000 | Tidak lagi dilacak |
| IRON | 30 Juni 2026 | 170.000 | $10.869.800 | 7,0% |
| NRIX | 30 Juni 2026 | 700.000 | $10.850.000 | 11,6% |
| KRYS | 30 Juni 2025 | 60.000 | $10.818.000 | 148,1% |
| COO | 30 Juni 2026 | 150.000 | $10.725.000 | 5,7% |
| JANX | 31 Maret 2025 | 200.000 | $10.708.000 | -34,9% |
| EHC | 31 Maret 2026 | 100.000 | $10.614.000 | 25,1% |
| ETNB | 30 Sep. 2025 | 1.050.000 | $10.311.000 | Tidak lagi dilacak |
| HUM | 31 Maret 2025 | 40.000 | $10.148.400 | 45,1% |
| DYN | 31 Des. 2025 | 800.000 | $10.120.000 | 34,9% |
| TMO | 30 Juni 2026 | 20.000 | $9.830.600 | 23,8% |
| MLTX | 30 Sep. 2025 | 200.000 | $9.440.000 | 121,2% |
| COO | 31 Maret 2025 | 100.000 | $9.193.000 | -10,2% |
| CELC | 30 Juni 2026 | 80.000 | $9.131.200 | -11,9% |
| CRL | 31 Maret 2026 | 45.000 | $8.976.600 | 68,2% |
| IQV | 31 Des. 2025 | 45.000 | $8.547.300 | 13,6% |
| EXAS | 31 Maret 2025 | 150.000 | $8.428.500 | Tidak lagi dilacak |
| RYTM | 31 Maret 2025 | 150.000 | $8.397.000 | 107,3% |
| SNDX | 30 Juni 2026 | 350.000 | $8.176.000 | -9,4% |
| VKTX | 30 Juni 2026 | 250.000 | $8.135.000 | -10,7% |
| TEVA | 30 Juni 2025 | 500.000 | $7.685.000 | 121,8% |
| BAX | 30 Sep. 2025 | 250.000 | $7.570.000 | 15,0% |
| MASI | 30 Juni 2025 | 45.000 | $7.497.000 | Tidak lagi dilacak |
| ACHC | 31 Des. 2025 | 300.000 | $7.428.000 | 88,7% |
| ABBV | 30 Sep. 2025 | 40.000 | $7.424.800 | 13,9% |
| KROS | 31 Maret 2025 | 450.000 | $7.123.500 | 7,3% |
| INSP | 31 Maret 2026 | 75.000 | $6.917.250 | 17,7% |
| HOLX | 31 Des. 2025 | 100.000 | $6.749.000 | Tidak lagi dilacak |
| XENE | 30 Juni 2025 | 200.000 | $6.710.000 | 92,3% |
| QDEL | 31 Maret 2025 | 150.000 | $6.682.500 | -58,8% |
| BMY | 30 Juni 2025 | 100.000 | $6.099.000 | 42,7% |
| CAPR | 30 Juni 2026 | 200.000 | $6.080.000 | -71,3% |
| IQV | 30 Juni 2026 | 35.000 | $5.968.900 | 32,6% |
| RNA | 30 Juni 2025 | 200.000 | $5.904.000 | -53,8% |
| BRKR | 31 Maret 2026 | 125.000 | $5.888.750 | 63,1% |
| BRKR | 31 Maret 2025 | 100.000 | $5.862.000 | 41,2% |
| VRNA | 30 Sep. 2025 | 60.000 | $5.674.800 | Tidak lagi dilacak |
| JNJ | 31 Des. 2025 | 30.000 | $5.562.600 | 29,1% |
| ILMN | 31 Maret 2025 | 40.000 | $5.345.200 | 164,7% |
| ATYR | 30 Sep. 2025 | 1.050.000 | $5.323.500 | -27,9% |
| VKTX | 30 Sep. 2025 | 200.000 | $5.300.000 | 32,5% |
| IQV | 30 Juni 2025 | 30.000 | $5.289.000 | 62,5% |
| PTGX | 30 Juni 2026 | 50.000 | $5.270.000 | 23,9% |
| WAT | 30 Sep. 2025 | 15.000 | $5.235.600 | 32,7% |
| PODD | 31 Maret 2025 | 20.000 | $5.221.400 | -44,4% |
| EVMN | 30 Juni 2026 | 225.000 | $5.172.750 | 5,6% |
| PTCT | 30 Juni 2025 | 100.000 | $5.096.000 | 44,6% |
| APLS | 31 Maret 2026 | 200.000 | $5.024.000 | Tidak lagi dilacak |
| PHVS | 31 Des. 2025 | 200.000 | $4.990.000 | 31,2% |
| CRSP | 30 Sep. 2025 | 100.000 | $4.864.000 | -8,1% |
| DYN | 30 Juni 2025 | 450.000 | $4.707.000 | 177,2% |
| MNMD | 31 Maret 2026 | 350.000 | $4.686.500 | Tidak lagi dilacak |
| WBA | 31 Maret 2025 | 500.000 | $4.665.000 | Tidak lagi dilacak |
| LH | 30 Juni 2025 | 20.000 | $4.654.800 | 26,6% |
| BDX | 30 Juni 2025 | 20.000 | $4.581.200 | 39,4% |
| ZBH | 30 Juni 2026 | 50.000 | $4.521.000 | 15,4% |
| TGTX | 31 Maret 2025 | 150.000 | $4.515.000 | 39,9% |
| CRNX | 30 Juni 2025 | 125.000 | $4.192.500 | 194,7% |
| ESPR | 31 Des. 2025 | 1.500.000 | $3.975.000 | Tidak lagi dilacak |
| PLRX | 31 Maret 2025 | 300.000 | $3.951.000 | -17,0% |
| GMED | 30 Juni 2025 | 50.000 | $3.660.000 | 44,5% |
| EYPT | 31 Maret 2026 | 200.000 | $3.654.000 | -57,8% |
| BNTX | 30 Juni 2025 | 40.000 | $3.642.400 | 7,7% |
| RARE | 30 Sep. 2025 | 100.000 | $3.636.000 | -13,2% |
| SWTX | 31 Maret 2025 | 100.000 | $3.613.000 | Tidak lagi dilacak |
| GPCR | 31 Maret 2026 | 50.000 | $3.477.500 | 5,5% |
| BBIO | 30 Juni 2025 | 100.000 | $3.457.000 | 91,4% |
| SGHT | 31 Maret 2026 | 425.000 | $3.370.250 | 113,8% |
| CI | 30 Juni 2025 | 10.000 | $3.290.000 | -16,3% |
| JSPR | 30 Sep. 2025 | 590.000 | $3.274.500 | -69,9% |
| CPRX | 30 Sep. 2025 | 150.000 | $3.255.000 | Tidak lagi dilacak |
| ZNTL | 31 Maret 2025 | 1.050.000 | $3.181.500 | 144,0% |
| GOSS | 31 Maret 2026 | 1.000.000 | $3.100.000 | -53,3% |
| IMCR | 30 Juni 2026 | 100.000 | $3.015.000 | 13,5% |
| VSTM | 30 Juni 2025 | 500.000 | $3.015.000 | 67,5% |
| MAZE | 30 Juni 2026 | 100.000 | $2.985.000 | -2,6% |
| OSCR | 31 Maret 2026 | 200.000 | $2.874.000 | 168,7% |
| ALKS | 30 Sep. 2025 | 100.000 | $2.861.000 | 60,2% |
| RGEN | 30 Juni 2025 | 20.000 | $2.544.800 | 42,0% |
| RCUS | 30 Sep. 2025 | 300.000 | $2.442.000 | 121,1% |
| STAA | 31 Maret 2025 | 100.000 | $2.429.000 | 31,6% |
| ARWR | 30 Juni 2025 | 175.000 | $2.229.500 | 458,2% |
| MREO | 30 Juni 2025 | 800.000 | $1.800.000 | -89,1% |
| TVTX | 31 Maret 2025 | 100.000 | $1.742.000 | 262,6% |
| BCRX | 31 Maret 2026 | 200.000 | $1.560.000 | 3,1% |
| UNCY | 30 Juni 2026 | 225.000 | $1.480.500 | 19,8% |
| SLN | 31 Maret 2025 | 200.000 | $1.376.000 | 370,2% |
| KYTX | 31 Maret 2025 | 350.000 | $1.309.000 | 329,8% |
| CABA | 30 Juni 2025 | 850.000 | $1.177.250 | 115,8% |
| CMPS | 31 Maret 2025 | 200.000 | $756.000 | 382,7% |
| PTNT | 30 Juni 2025 | 1.000.000 | $582.900 | Tidak lagi dilacak |
| FATE | 30 Juni 2025 | 700.000 | $553.070 | 122,9% |